The Patent Finder

Recro Technology LLC

Also on record
Records under this name other than patents Recro Technology LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Recro Technology LLC

PatentTitleStatus Expires Confidence
US 8,992,973Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride
Formerly held
Term ended
Term ended Oct 31, 2025 · High confidence
Term endedTerm ended Oct 31, 2025High confidence
US 10,213,389Controlled Release Compositions Comprising A Combination Of Isosorbide Dinitrate And Hydralazine Hydrochloride
Formerly held
Term ended
Term ended Oct 31, 2025 · Medium confidence
Term endedTerm ended Oct 31, 2025Medium confidence
US 8,512,727Nanoparticulate meloxicam formulations
Formerly held
Lapsed on the fee record
Ended Aug 20, 2025 · High confidence
Lapsed on the fee recordEnded Aug 20, 2025High confidence
US 8,323,641Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Formerly held
Lapsed on the fee record
Ended Dec 4, 2024 · High confidence
Lapsed on the fee recordEnded Dec 4, 2024High confidence
US 9,463,166Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride
Formerly held
Lapsed on the fee record
Ended Oct 11, 2024 · Medium confidence
Lapsed on the fee recordEnded Oct 11, 2024Medium confidence
US 9,308,177Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride
Formerly held
Lapsed on the fee record
Ended Apr 12, 2024 · Medium confidence
Lapsed on the fee recordEnded Apr 12, 2024Medium confidence
US 10,463,673Nanoparticulate Meloxicam Formulations
Formerly held
Term ended
Term ended Feb 24, 2024 · Medium confidence
Term endedTerm ended Feb 24, 2024Medium confidence
US 10,471,067Nanoparticulate Meloxicam Formulations
Formerly held
Term ended
Term ended Feb 24, 2024 · Medium confidence
Term endedTerm ended Feb 24, 2024Medium confidence
US 10,709,713Nanoparticulate Meloxicam Formulations
Formerly held
Term ended
Term ended Feb 24, 2024 · Medium confidence
Term endedTerm ended Feb 24, 2024Medium confidence
US 6,908,626Compositions Having a Combination of Immediate Release and Controlled Release Characteristics
Formerly held
Term ended
Term ended Dec 25, 2022 · High confidence
Term endedTerm ended Dec 25, 2022High confidence
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited